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In 1991, Carl Nathan and I published a mini-review in the
Journal of Cell Biology [1] entitled "Cytokines in Context." In that
review we suggested that cytokine research was in a state of chaos,
largely because of the failure to appreciate the contextual nature
of the action of these peptides. We noted a series of questionable
assumptions that were then current in the field, including the
concepts that a cytokine functions principally within the area of its
discovery, that a cytokine is synthesized chiefly in a particular cell
type, that a cytokine has a principal action reflected in its name,
and that cytokines can be classified as either "stimulatory" or
"inhibitory." All of these assumptions were of dubious validity at
that time, and they remain so.
Five years later, the situation has only become more chaotic,
since the multifunctional nature of cytokines is now more exten-
sively documented in greater breadth and detail. Whether one is
considering representatives of many classes of cytokines by any
name, whether they be called interleukins, colony stimulating
factors, interferons, or peptide growth factors, it is now known
beyond question that these molecules have domains of function
far removed from their original area of discovery, that they can be
synthesized by a wide array of cells, that it is impossible to
describe a principal mode of action for most of them, and that
they can have both positive and negative effects on specific cell
functions, depending on the state of the target cell. We com-
mented that, "given the amino acid sequence of a cytokine and
any of its actions, we cannot predict when and where it will do
what else" [1]. This viewpoint has been extensively validated in the
past five years. One has only to look at the myriad of biological
effects that are known to be mediated by transforming growth
factor-a (TGF-f3), interleukin-6 (IL-6), tumor necrosis factor
(TNF), and the many isoforms of fibrohiast growth factor (FGF),
to name just a few examples, for such validation.
In this very brief review, I will expand on some of the points
made previously, and suggest that it is only through further studies
of the overall context of cytokine function, particularly the
manner in which cytokines are used as a language to modulate the
interactions of cells and tissues with their environment, that we
will be able to understand their true roles in the physiology of the
organism. As noted previously [2, 3], cytokines provide an essen-
tial means for a cell to communicate with its immediate environ-
ment and to ensure that there is proper local homeostatic balance
between the cells that comprise a tissue. Since a cell must adjust
its behavior to changes in its environment, it needs mechanisms to
provide this adaptation. Cytokines are thus used as autocrine and
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paracrine signals, which can be either negative or positive, de-
pending on the immediate context, to stabilize the local microen-
vironment in which cells exist. Above all, cytokines are not little
people that reside within cells, as many observers have attempted
to portray them. Three hundred years ago, it was believed that
there was a homunculus (a little man) inside the head of the
sperm, and this type of animistic thinking still persists in our use
of terms such as "growth factors," "oncogenes," and "tumor
suppressor genes," in that we attempt to provide a persona to
molecules that merely do what they do. Thus, the molecules that
we name as "growth factors.,"" oncogenes," and "tumor suppres-
sor genes" in reality are contextual regulatory elements that
control multiple cellular functions, rather than being the specific
agents that the current terminology implies.
In any discussion of the contextual action of cytokines, the role
of the extracellular matrix as a modulator of their overall physi-
ology must considered. The importance of the extracellular matrix
in acting as a critical interface between the cell and its environ-
ment is now well established and widely recognized, and the
significant role of the matrix as a mediator of events within the cell
is generally accepted. This concept has become conventional
wisdom, but such was hardly the case less than 20 years ago, when
Bissell, Hall and Perry [4] proposed their theory of "dynamic
reciprocity" between cells and their extracellular matrix. The
synthesis and function of many cytokines is now known to be
modulated by the interactions of cells with their extracellular
matrix, thus providing an important contextual link between the
cell and its environment. Indeed, inasmuch as the extracellular
matrix of a cell reflects its metabolic history, the matrix can be
regarded as a rudimentary memory of past events. As cytokine
research progresses, it will become increasingly important to focus
on the elucidation of the specific mechanisms mediating this
dynamic reciprocity between the cell and its immediate environ-
ment.
As noted previously [1], it is already known that adherence of
cells to matrix can induce cells to make cytokines; that, in turn,
cytokines can be highly active in inducing cells to alter their
matrix; that the extracellular matrix can regulate the presentation
of cytokines to cells, thus controlling whether or not a cytokine
may be recognized by its specific receptors; that cytokines control
the expression of cell adhesion receptors; that adhesion receptors,
in turn, can have physiological actions that closely resemble those
of cytokine receptors; that some cytokine receptors, acting in a
juxtacrine fashion, can enhance cell-cell adhesion; and finally, that
the adhesiveness of cells can determine how they will respond to
cytokines.
There is thus a very extensive network that involves the
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interactions of cytokines with their immediate macromolecular
extracellular environment, and this network allows the external
environment to determine many aspects of cellular behavior.
These interactions, as well as events occurring in the genome,
must be considered if there can be a valid understanding of tissue
function. In an elegant review of environmental interactions with
the genome, Strohman [5] emphasized the importance of what he
calls the "epigenetic informational system," which he considers to
be inserted between unitary genetic elements and the final
phenotype, as a critical mediator of cell behavior. He notes that
simplistic linear connections between single genes and disease
suffice to explain only a tiny fraction of human disease, and that a
more sophisticated epigenetic view, which sees disease influenced
by many genes not only interacting with one another but also with
environmental signals, is necessary to account for almost all of the
most common human diseases, including cardiovascular disease,
cancer, and mental illness.
Garrod's paradigm of simple genetic determinism, which en-
abled him to map a rare disease, alkaptonuria, to a Mendelian
inheritance pattern, was a monumental contribution to modern
medical science. However, this paradigm is far too simple to deal
with the real world of polygenic disease, and to explain the known
influence that the environment plays on patterns of gene expres-
sion. It is exactly in this area of epigenetie regulation of cell
function that cytokines play such an important role. They are
critical signalling molecules that provide environmental informa-
tion to the cell and thereby enable the cell to make appropriate
responses to the environment. Many of these actions of cytokines
involve the regulation of gene function, and specific response
elements on DNA are key targets of cytokines. However, as noted
below, proteins may turn up in expected locations, and not all
actions of cytokines need involve control of gene transcription,
however popular this area of investigation is at the present time.
Three aspects of the contextuality of cytokines
Cytokines are multifunctional
It has been known for some time that an individual cytokine
may have both positive and negative regulatory actions in a
particular cell or tissue, depending on the immediate constellation
of events in that cell or tissue. Transforming growth factor-p
(TGF-p) was one of the first cytokines for which this paradigm
was elucidated, and we have summarized this situation with the
concept that TGF-13 is a cellular switch: if something in the cell is
"off," TGF-f3 will turn it "on," while if something is "on," TGF-j3
will turn it "off" [6]. Recent studies on the role of TGF-3 in skin
carcinogenesis have extended this concept of TGF-13 as a switch,
which further allows cells and tissues to make different responses
in different contexts [7]. Transgenic mice were created in which
TGF-pl expression was targeted to keratinocytes. These mice
were then exposed to a standard initiation-promotion carcinogen-
esis protocol, using the carcinogen, dimethylbenzanthraeene, as
initiator and the phorbol ester, TPA, as promoter. Interestingly,
the transgenic mice expressing elevated levels of TGF-13 were
protected from development of early, benign tumors; thus,
TGF-pl acted as a suppressor of early stages of tumorigenesis.
However, the opposite situation occurred at a later stage in
carcirlogenesis: here TGF-pl enhanced progression of the benign
tumors to invasive spindle cell carcinomas.
Tumor necrosis factor (TNF) provides yet another example of
our inability to predict whether the action of a cytokine is
beneficial or detrimental to the welfare of the intact organism.
TNF clearly plays a detrimental role outside of the nervous sytem
during septic shock, and there have been many attempts in the
biotechnology world to develop various antagonists to TNF for
the treatment of this condition. However, recent studies in which
TNF function has been eliminated by the genetic knockout of
TNF receptors indicate that TNF has a definite beneficial role in
the nervous system in vivo, as well as in neuronal cell culture in
vitro. TNF activity was found to protect the nervous system from
both anoxic and oxidative stress [8], in contrast to its life-
threatening actions on the cardiovascular system during septic
shock.
The concept of multifunctionality is clearly applicable to many
other peptide regulatory molecules, which are not even eytokines.
Thus, one now has the highly confusing situation in which a given
transcription factor can function both as "oncogene" and "tumor
suppressor gene." Recent studies have shown that E2F transcrip-
tion factors can participate in two diametrically opposite effects on
transcription [9]. When complexed directly to DNA in the absence
of pRB, the E2Fs act as strong inducers of transcription, while in
the presence of pRB, they repress transcription. Mice in which
E2F genes were knocked out had a totally unexpected phenotype.
Based on the known actions of E2Fs as enhancers of progression
through the cell cycle, it was expected that the knockout mice
would show underdevelopment or absence of specific tissues.
Instead, these mice were found to have tumors at multiple sites.
So how do we rationalize these "conflicting" actions? Rather than
considering that these actions are "conflicting," it would seem that
the problem here is one of terminology, particularly with our
notion that a given molecule should have a single action. We have
made the transcription factor into a homunculus, rather than
considering that it is merely an element in a regulatory code.
Cytokines may have different actions in different locations
in the cell
An important corollary to the concept that a given regulatory
molecule may be multifunctional is the realization that such a
molecule may reside in different compartments within the cell,
and thus mediate different activities in these separate compart-
ments. In a thought-provoking recent review [10], Smalheiser
summarized data for many proteins that do not fit the "one
protein, one compartment" concept. He notes that members of
many classes of proteins, including cytokines and transcription
factors, have been identified in cellular compartments other than
their conventional sites of action. The action of a protein at a new
site within the cell may he correlated with specific adaptive
responses to stresses, such as wounding or heat-shock.
TGF-p again provides an interesting example as to how a single
regulatory molecule may be used for different purposes in differ-
ent compartments of the cell. Several years ago we showed that
significant levels of TGF-pl could be detected in mitochondria of
rat and mouse cardiac myocytes and rat hepatocytes [11]. The
techniques used to establish this finding included electron micros-
copy and cell fractionation; both methods employed a series of
specific antibodies to ensure that these very surprising and
unexpected findings were not artifactual. Recovery studies
showed that the majority of native TGF-pl found in rat liver
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homogenates was located in highly pure mitochondrial fractions.
The role of TGF-/3 in the mitochondrion remains an enigma. We
suggested that just as TGF-f3 acting at its external cell membrane
receptors might serve to couple the cell to its external environ-
ment, so might mitochondrial TGF-/3 act as a linker between the
energetics of the cell and the cell's other activities. This remains a
valid speculation. Clearly, TGF-3 within the mitochondrion has a
different function from TGF-f3 that is released from platelets or
macrophages during tissue repair. The context of the cellular
location of a cytokine thus needs to be considered if one wishes to
account for its function.
Cytokines may also have different actions in different time frames
This concept is a speculation. We have previously noted that we
consider TGF-p to be a cellular switch [61, and that in an organ
such as the heart, TGF-/3 might mediate a cyclical intracellular
function over very short time periods, such as those associated
with the contractile function of myocytes. The immunolocaliza-
tion of the epitope corresponding to amino acids 50 to 75 of
TGF-pl in the contractile filaments of cardiac myocytes [111 gives
some experimental basis for such a possibility. One could thus
envision that TGF-J3 might be reversibly phosphorylated, acylated,
alkylated, nitrosylated, over very short time periods, much in the
same manner as an enzyme. Such a chemical modification need
not be on TGF-3 itself; modification of the latency protein (LAP)
associated with TGF-J3 could also serve to provide a transient,
cyclical alteration in the function of TGF-j3 itself. Considering the
tremendous versatility of the TGF-f3 ligand-receptor system,
which acts over relatively long durations of time at the cell surface,
it is reasonable to suggest that TGF-p may have short-term
effects, still to be discovered, within the the cell itself.
Conclusions
We must continue to study cytokines in their natural context if
we wish to understand their actions. Reductionism that fails to
account for the interactions between the environment and cyto-
kines will also fail to account for a satisfactory explanation of the
overall physiology of cytokines. Simple animistic models that
neglect the complexity of function of cytokines as mediators of the
interactions between the various cells that comprise tissues will be
inadequate to explain the complexity of the pathogenesis of most
chronic human diseases.
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